R&D News | pharmaphorum

News

Top-line phase 2 results with Amgen's MariTide drug for obesity are finally in, but don't seem to have lived up to investor expectations

News

Medigene slashes staff and delays trials of its lead TCR therapy candidate as it refocuses its pipeline

News

Roche has upgraded its partnership with off-the-shelf CAR-T therapy specialist Poseida to a $1 billion-plus takeover bid

News

ZENITH trial of MSD's Winrevair in PAH could add further momentum to an already impressive launch

News

Cassava Sciences' troubled development of Alzheimer's disease candidate simufilam looks like it may have finally reached the end

News

After a disappointing result with Truqap in triple-negative breast cancer, AstraZeneca chalks up a win in prostate cancer